Becton Dickinson and Co news

   Watch this stock
Showing stories 1 - 10 of about 14   

Articles published

BDX 167.28 +0.28 (0.17%)
price chart
Recent cases show that utilitarian functionality is a serious – and common ...
In other words, courts may consider whether alternative product designs are available, and whether the cost or time involved in using an alternative design makes it impractical.
Asuragen Grants Armored RNA� Technology License to BD
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has granted BD (Becton, Dickinson and Company), a global medical technology company, non-exclusive worldwide rights to incorporate Armored RNA� technology into its in vitro ...
Ezose Sciences Announces Appointment of Chief Operating Officer
Earlier, he held various positions in New Business Development and Worldwide Strategic Marketing at Johnson & Johnson. He has served in R&D capacities at Phytera, Inc., Centocor, Inc., and Becton Dickinson and Co., and as Adjunct Associate Professor of ...
DaVita to Cut Energy Use 15% Per Treatment by 2015
Dialysis provider DaVita Inc. plans to cut its energy consumption 15 percent per treatment by 2015 as part of a larger environmental initiative.
TEXT-S&P affirms Hologic 'BB' rating
Hologic will continue facing challenges in improving its products against such substantial competitors as Johnson & Johnson, General Electric Co.
Gerhard Kallmann, Architect, Is Dead at 97
His death was confirmed by Mr. McKinnell, who co-founded what was known as Kallmann, McKinnell & Knowles in 1962, the year their fledgling firm rattled the architectural community by winning a national competition to design Boston City Hall.
Gerhard Kallmann, 97; architect who co-designed Boston City Hall
He was most involved in designing the Boston Five Cent Savings Bank, the gymnasium at Phillips Exeter Academy, the Becton Dickinson corporate campus in New Jersey, and Hauser Hall and Shad Hall at Harvard. “He and his firm really set a very high ...
IPO Releases List of Top 300 Patent Holders for 2011
Life sciences companies and organizations that failed to make the IPO top 300 in 2011 after making it in 2010 included Boehringer Ingelheim International GmbH (#260 on the IPO top 300 for 2010), Becton, Dickinson and Co. (263), Columbia University (272 ...
Predicting En Banc Issues
In the two years prior to the Federal Circuit's grant of en banc review of inequitable conduct in Therasense v. Becton Dickinson, for example, there were four dissents on the issue of inequitable conduct. On the other hand, in the two years prior to ...
Stocks with Increasing Sales and Profit Margins
With earnings season only a few weeks away, now is the perfect time to look at this. So let's start at the beginning: first and foremost, sales are THE most important thing to a company. Everything else stems from that. Without sales, there really ...